Speaker illustration

Professor Dirk van Veldhuisen

University Medical Centre Groningen, Groningen (Netherlands (The))

Member of:

European Society of Cardiology
Heart Failure Association

Acute heart failure - epidemiology, prognosis, outcome 1

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Novel approaches to the treatment of heart failure: a summary

Event: ESC Congress 2021 - The Digital Experience

Topic: Chronic Heart Failure

Session type: Official Joint Session

Thumbnail

Meet the Experts - Heart failure drug therapy in patients with co-morbidities

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session type: Focus with the Experts

Thumbnail

The European Heart Journal’s advances in heart failure and valvular heart disease

Event: ESC Congress 2019

Topic: European Society of Cardiology

Session type: Special Session

Thumbnail

Antithrombotics in heart failure

Event: Heart Failure 2018

Topic: Atrial Fibrillation (AF)

Session type: Symposium

Thumbnail

Lessons learnt from recent clinical trial outcomes

Event: Heart Failure 2018

Topic: Cardiac Biology and Physiology

Session type: Symposium

Thumbnail

Novel concepts and treatments of comorbidities in heart failure with preserved ejection fraction

Event: Heart Failure 2018

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Thumbnail

The right ventricle: the bright side of the moon

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Right ventricular function

Session type: Symposium

Thumbnail

Arrhythmias in heart failure – What are the mechanisms?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Arrhythmias and treatment

Session type: Symposium

Thumbnail

Iron deficiency in patients with heart failure: time for action

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Anaemia and iron deficiency

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb